|
Merck, Roche Aim to Capture Hep C Market Via Collaboration
To secure a greater market share for its recently approved hepatitis C (HCV) treatment Victrelis, Merck will collaborate with Roche to promote both companies’ HCV drugs for the disease.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
|
Subscribe
Archives